Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-17-003023

Director acquired 1,200 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Smith Robin L Director 2017-02-03 Option exercise +1,200 $7.65 $9,180 1,900 D
Derivatives
Smith Robin L Director 2017-02-03 Option exercise · Stock Option (Right to Buy) −1,200 0 D
Loading xslF345X03/doc4.xml…